147 related articles for article (PubMed ID: 9047255)
1. Adenosquamous carcinoma arising in a mucinous cystadenoma of the pancreas.
Campman SC; Fajardo MA; Rippon MB; Kraegel SA; Ruebner BH
J Surg Oncol; 1997 Feb; 64(2):159-62. PubMed ID: 9047255
[TBL] [Abstract][Full Text] [Related]
2. Mixed serous cystadenoma with mucinous cystadenoma of the pancreas.
Abe H; Kimura W; Mori M; Makuuchi M; Yanagisawam A
Pancreas; 2005 Jul; 31(1):98-100. PubMed ID: 15968256
[TBL] [Abstract][Full Text] [Related]
3. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy.
Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T
Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860
[TBL] [Abstract][Full Text] [Related]
4. Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases.
Yamaguchi K; Chijiiwa K; Noshiro H; Torata N; Kinoshita M; Tanaka M
Hepatogastroenterology; 1999; 46(28):2575-81. PubMed ID: 10522044
[TBL] [Abstract][Full Text] [Related]
5. Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas.
Kim SG; Wu TT; Lee JH; Yun YK; Issa JP; Hamilton SR; Rashid A
Mod Pathol; 2003 Nov; 16(11):1086-94. PubMed ID: 14614047
[TBL] [Abstract][Full Text] [Related]
6. Colloid (mucinous noncystic) carcinoma of the pancreas.
Adsay NV; Pierson C; Sarkar F; Abrams J; Weaver D; Conlon KC; Brennan MF; Klimstra DS
Am J Surg Pathol; 2001 Jan; 25(1):26-42. PubMed ID: 11145249
[TBL] [Abstract][Full Text] [Related]
7. Macrocystic pancreatic cystadenoma: The role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions.
O'Toole D; Palazzo L; Hammel P; Ben Yaghlene L; Couvelard A; Felce-Dachez M; Fabre M; Dancour A; Aubert A; Sauvanet A; Maire F; Lévy P; Ruszniewski P
Gastrointest Endosc; 2004 Jun; 59(7):823-9. PubMed ID: 15173795
[TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma of the ovary arising from a mucinous cystic tumor of endocervical (müllerian) type.
D'Angelo E; Dadmanesh F; Pecorelli S; Prat J
Int J Gynecol Pathol; 2010 Nov; 29(6):529-32. PubMed ID: 20881861
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous mucinous cystadenoma of ovary and mucinous cystadenocarcinoma of pancreas.
Gagne LJ; Colacchio T; Longnecker DS
Int J Pancreatol; 2000 Aug; 28(1):9-13. PubMed ID: 11185714
[TBL] [Abstract][Full Text] [Related]
10. Cystic neoplasms of the pancreas.
Yamaguchi K; Enjoji M
Gastroenterology; 1987 Jun; 92(6):1934-43. PubMed ID: 3471621
[TBL] [Abstract][Full Text] [Related]
11. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy.
Jimenez RE; Warshaw AL; Z'graggen K; Hartwig W; Taylor DZ; Compton CC; Fernández-del Castillo C
Ann Surg; 1999 Oct; 230(4):501-9; discussion 509-11. PubMed ID: 10522720
[TBL] [Abstract][Full Text] [Related]
12. A comparative analysis of K-ras mutation and carcinoembryonic antigen in pancreatic cyst fluid.
Talar-Wojnarowska R; Pazurek M; Durko L; Degowska M; Rydzewska G; Smigielski J; Janiak A; Olakowski M; Lampe P; Grzelak P; Stefanczyk L; Smolarz B; Malecka-Panas E
Pancreatology; 2012; 12(5):417-20. PubMed ID: 23127529
[TBL] [Abstract][Full Text] [Related]
13. Invasive Ductal Carcinoma Arising in Mucinous Cystic Neoplasm of Pancreas: A Case Report.
Sawai H; Kurimoto M; Koide S; Kiriyama Y; Haba S; Matsuo Y; Morimoto M; Koide H; Kamiya A; Yamao K
Am J Case Rep; 2019 Feb; 20():242-247. PubMed ID: 30798329
[TBL] [Abstract][Full Text] [Related]
14. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid.
Sawhney MS; Devarajan S; O'Farrel P; Cury MS; Kundu R; Vollmer CM; Brown A; Chuttani R; Pleskow DK
Gastrointest Endosc; 2009 May; 69(6):1106-10. PubMed ID: 19249035
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of expression of molecular biologic factors in intraductal papillary-mucinous tumors of pancreas--diagnostic and biologic significance.
Islam HK; Fujioka Y; Tomidokoro T; Sugiura H; Takahashi T; Kondo S; Katoh H
Hepatogastroenterology; 1999; 46(28):2599-605. PubMed ID: 10522048
[TBL] [Abstract][Full Text] [Related]
16. Identical, unique p53 mutations in a primary ovarian mucinous adenocarcinoma and a synchronous contralateral ovarian mucinous tumor of low malignant potential suggest a common clonal origin.
Werness BA; DiCioccio RA; Piver MS
Hum Pathol; 1997 May; 28(5):626-30. PubMed ID: 9158713
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study.
Khalid A; Zahid M; Finkelstein SD; LeBlanc JK; Kaushik N; Ahmad N; Brugge WR; Edmundowicz SA; Hawes RH; McGrath KM
Gastrointest Endosc; 2009 May; 69(6):1095-102. PubMed ID: 19152896
[TBL] [Abstract][Full Text] [Related]
18. K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases.
Cuatrecasas M; Villanueva A; Matias-Guiu X; Prat J
Cancer; 1997 Apr; 79(8):1581-6. PubMed ID: 9118042
[TBL] [Abstract][Full Text] [Related]
19. Primary retroperitoneal mucinous cystadenoma with a sarcoma-like mural nodule: an immunohistochemical study with histogenetic considerations and literature review.
Demirel D; Gun I; Kucukodaci Z; Balta AZ; Ramzy I
Int J Gynecol Pathol; 2013 Jan; 32(1):15-25. PubMed ID: 23202791
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
